Skip to content
Clinical Trials – home

Centre Hospitalier De Bourg-En-Bresse

Verified siteinfo

France 900 Route De Paris, 01000 Bourg En Bresse, France

  • 11 trials recruiting
  • Hormone receptor positive HER2 negative breast cancer · Plasma cell myeloma · Breast cancer
  • Adults and children

About Specializations

Centre Hospitalier De Bourg-En-Bresse in Bourg En Bresse, France specialises in clinical trials of conditions such as Hormone receptor positive HER2 negative breast cancer, Plasma cell myeloma, Breast cancer, Acute respiratory failure, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Centre Hospitalier De Bourg-En-Bresse, clinical research in cardiovascular diseases focuses on acute ischemic stroke and high-risk transient ischemic attack. These studies are designed to assess whether new treatment approaches can better prevent recurrent stroke and improve protection after a recent cerebrovascular event.

  • Evaluating whether a new therapy can lower the risk of another ischemic stroke after a recent event
  • Studying treatment strategies for patients with acute stroke-related conditions
  • Improving care for people at high risk of further neurological complications

This area reflects a strong interest in better prevention and treatment of serious cerebrovascular disease in the intensive care setting.

Bacterial Infections and Mycoses

Research in bacterial infections at this site centers on severe community-acquired bacterial pneumonia. The trials are exploring whether adding new supportive treatments to standard care can improve recovery, while also checking their safety and tolerability in patients with serious lung infection.

  • Testing a potential new treatment for severe pneumonia
  • Assessing whether patients recover faster when additional therapy is used with standard care
  • Evaluating the safety and tolerability of infection-focused treatment approaches

This work highlights the site’s role in studying better ways to manage serious respiratory infections that can lead to critical illness.

Respiratory Tract Diseases

In the area of respiratory tract diseases, the Unité de soins intensifs is involved in research on de novo acute respiratory failure. The main goal is to improve treatment pathways and help patients come off high-flow nasal oxygen therapy more successfully.

  • Studying a protocol to support safer and more effective weaning from oxygen therapy
  • Looking at ways to increase the chance of being off high-flow oxygen by day 7
  • Improving recovery for patients with acute breathing failure in intensive care

These trials focus on practical care improvements for patients with acute respiratory failure, aiming to strengthen outcomes in the intensive care environment.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
900 Route De Paris01000 Bourg En BresseFrance
Recruiting now
11 trials
Conditions studied
23
Partner status
Verified site

More sites in Bourg En BresseFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

30 clinical trials

Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer

Study of Trastuzumab Deruxtecan and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Who Have Not Received Prior Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pertuzumab
  • Sponsor:Solti Group

Sepsis

Recruiting

Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Assistance Publique Hopitaux De Paris

Study of High-Flow Nasal Oxygen During Intubation in Intensive Care Patients with Low Blood Oxygen Levels

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Intergroupe Francophone Du Myelome

Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Unicancer

Study Comparing Continuous and Fixed Duration Therapy with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Relapsed Multiple Myeloma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on Weaning Patients with Acute Respiratory Failure from High-Flow Nasal Oxygen Therapy Using Oxygen

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Obesity

Recruiting

Study on Vitamin D Deficiency Treatment in Obese Children and Adolescents Using Colecalciferol: Comparing Monthly Boluses and Daily Doses

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Colecalciferol
  • Sponsor:Hospices Civils De Lyon
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Astrazeneca AB

Study on Reducing Treatment for Patients with HER2-Positive Metastatic Breast Cancer Using Trastuzumab and Drug Combination After 2 Years of Controlled Disease

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pertuzumab
  • Sponsor:Unicancer

Pneumonia+1

Not yet recruiting

Early Use of Dexamethasone versus Sodium Chloride Placebo in Patients with Severe Influenza-Induced Acute Hypoxemic Respiratory Failure (Phase III Randomized Trial)

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospital Region Metz Thionville
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.